Immunology and Immunotherapy
A section of Biomedicines (ISSN 2227-9059).
Section Information
This section publishes reviews and original peer-reviewed papers of a high scientific level covering all the aspects of immunology and oncoImmunology. Papers aim to uncover the modulations of the immune system, active and passive immunotherapies, the diagnostic test based on specific markers and the use of new technologies to identify novel predictive factors to respond to immunotherapy. Topics include, but are not limited to in vivo/in vitro immune responses research; targeted therapies (including antibody research and vaccine research); virotherapy and oncolytic vaccines; use of nanoparticles and microvesicles for developing immunotherapeutics; etc.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Targeted Biologic Therapies for Allergic Conditions: From Bench to Bedside (Deadline: 30 April 2026)
- Rheumatic Diseases: From Pathophysiology to Current and Emerging Therapeutic Approaches (Deadline: 30 April 2026)
- The Role of Polyamines in Human Health and Disease—Second Edition (Deadline: 30 April 2026)
- Targeting Mast Cells in Human Disease: Bridging Pathology and Therapy (Deadline: 30 April 2026)
- New Insights into the Tumor Microenvironment: Mechanisms and Therapeutic Strategies (Deadline: 30 April 2026)
- New Trends in Cancer Immunotherapy (Deadline: 31 May 2026)
- mRNA Personalized Cancer Vaccines and Immune-Oncology (Deadline: 31 May 2026)
- New Advances in Immunology and Immunotherapy (Deadline: 31 May 2026)
- Immunometabolism in Cancer and Autoimmunity: Mechanisms and Therapeutic Targeting (Deadline: 31 May 2026)
- Allergic Rhinitis: From Pathology to Novel Therapeutic Approaches (Deadline: 31 May 2026)
- Immune Checkpoint Regulation and Signaling Pathways in Cancer (Deadline: 31 May 2026)
- Convergence of Allergology and Immunology: Unveiling Mechanistic Insights (Deadline: 31 May 2026)
- Molecular Mechanism in Inflammation and Immunity: 2nd Edition (Deadline: 29 June 2026)
- Lipid Nanoparticles for Cancer Immunotherapy (Deadline: 30 June 2026)
- Thyroid Disorders: Comprehensive Insight from Functional Abnormalities, Structural Lesions to Autoimmunity (Deadline: 30 June 2026)
- Oxidative Stress and Inflammation: From Mechanisms to Therapeutic Approaches (4th Edition) (Deadline: 30 June 2026)
- Immunology in Recurrent Pregnancy Loss, Preeclampsia and Infertility (Deadline: 30 June 2026)
- State-of-the-Art Immunology and Immunotherapy in Europe (2nd Edition) (Deadline: 30 June 2026)
- Photodynamic Therapy (4th Edition) (Deadline: 15 July 2026)
- Immune Checkpoint Blockade and Beyond: Next-Generation Cancer Immunotherapies (Deadline: 30 July 2026)
- Rewiring Immune Fate: Immunometabolic and Epigenetic Mechanisms in Therapeutic Immunomodulation in Inflammation, Aging, and Cancer (Deadline: 31 July 2026)
- The Renin–Angiotensin System in Immune Regulation: Roles in Blood, Vessels, and Inflammation (Deadline: 31 July 2026)
- Advances in Extracellular Vesicles in Therapeutics (Deadline: 31 July 2026)
- The Role of Immunity and Inflammation in Cardiovascular Diseases (Deadline: 31 July 2026)
- Mechanism and Clinical Perspective: Pathogens of Infectious Respiratory Diseases (Deadline: 31 July 2026)
- BK Polyomavirus: Immunopathology and Therapeutic Approaches (Deadline: 31 July 2026)
- Pathomechanisms of Disturbances Underlying Chronic Disorders—Third Edition (Deadline: 31 July 2026)
- Omics Approaches on Immune-Mediated Inflammatory Diseases: Towards Novel Biomarkers and Potential Therapeutic Targets, 3rd Edition (Deadline: 31 August 2026)
- Oncolytic Viruses and Combinatorial Immunotherapy for Cancer (2nd Edition) (Deadline: 31 August 2026)
- Emerging Therapies, Diagnostic Approaches, and Mechanistic Insights in Allergic Diseases (Deadline: 31 August 2026)
- Immune Tolerance in Transplantation: Mechanisms and Therapeutic Strategies (Deadline: 31 August 2026)
- Biologic Drugs: The Evolution of Asthma Therapeutics (Deadline: 31 August 2026)
- Inflammatory Bowel Diseases: New Diagnostic and Therapeutic Approaches—Second Edition (Deadline: 31 August 2026)
- The Molecular Basis of the Immune Response in Pulmonary Fibrosis (Deadline: 30 September 2026)
- Sepsis and Systemic Inflammation: Mechanisms and Therapeutic Innovations (Deadline: 30 September 2026)
- Immunometabolism in Disease Development (Deadline: 30 September 2026)
- The Pivotal Role of Mucosal Immunity in Health and Disease (Deadline: 30 September 2026)
- Emerging Trends in Cardioimmunology: Pathomechanisms and Therapeutic Strategies (Deadline: 30 September 2026)
- Biological and Targeted Therapies in Rheumatic Diseases (Deadline: 30 October 2026)
- Innovations and Perspectives in Kidney Transplantation (Deadline: 31 October 2026)
- Advances in Immunometabolism: Molecular Pathways, Regulatory Networks, and Therapeutic Opportunities (Deadline: 31 October 2026)
- Transplantation Immunology: Mechanism, Challenges, and Innovations (Deadline: 31 October 2026)
- Targeted Immunotherapy: Shared Targets and Technologies in Oncology and Autoimmune Disorders (Deadline: 31 October 2026)
- Phenotypes and Endotypes in Interstitial Lung Diseases—Second Edition (Deadline: 31 October 2026)
- New Insights in Immunological Pathways (Deadline: 31 October 2026)
- Immunotherapy and Immune-Related Adverse Events in Cancer (Deadline: 31 October 2026)
- Immune Cell Reprogramming: Molecular Mechanisms and Therapeutic Approaches (Deadline: 30 November 2026)
- Recent Advances in Diagnosis and Therapeutic Strategies in Intraocular Inflammation—Second Edition (Deadline: 30 November 2026)
- Autoimmune and Inflammatory Disorders: From Pathogenesis to Therapeutic Targeting (Deadline: 30 November 2026)
- Pancreatitis: Aetiology, Pathology, and Treatment (Deadline: 31 December 2026)
Topical Collections
Following topical collections within this section are currently open for submissions:
